GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » 5-Year Dividend Growth Rate

HLS Therapeutics (HLS Therapeutics) 5-Year Dividend Growth Rate : 10.60% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics 5-Year Dividend Growth Rate?

HLS Therapeutics's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

During the past 12 months, HLS Therapeutics's average Dividends Per Share Growth Rate was -52.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -19.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of HLS Therapeutics was 59.00% per year. The lowest was -19.50% per year. And the median was 22.80% per year.

HLS Therapeutics's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, HLS Therapeutics's Dividend Yield % is 1.05%.

Warning Sign:

HLS Therapeutics Inc stock dividend yield is close to 3-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of HLS Therapeutics's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLS Therapeutics's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where HLS Therapeutics's 5-Year Dividend Growth Rate falls into.



HLS Therapeutics 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


HLS Therapeutics  (OTCPK:HLTRF) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

HLS Therapeutics's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -0.136
=N/A

During the past 13 years, the highest Dividend Payout Ratio of HLS Therapeutics was 0.25. The lowest was 0.25. And the median was 0.25.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of HLS Therapeutics was 15.69%. The lowest was 0.32%. And the median was 2.05%.

Warning Sign:

HLS Therapeutics Inc stock dividend yield is close to 3-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLS Therapeutics 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


HLS Therapeutics (HLS Therapeutics) Business Description

Traded in Other Exchanges
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (HLS Therapeutics) Headlines

From GuruFocus

Automodular Corp. (TSX:AM) - Strong Buy

By Elliot Luchansky, CFA Elliot Luchansky, CFA 03-21-2013